Biomarkers of Neurological Injury and Recovery in Urea Cycle Disorders
Biomarkers of Neurological Injury and Recovery in Urea Cycle Disorders
批准号:
8916161
负责人:
Andrea Lynne Gropman
金额:
$10.01万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2019-07-31
关键词:
AcuteAffectAgeAmmoniaAnisotropyArgininosuccinate lyase deficiencyAtrophicAttentionBerryBiochemicalBiochemical MarkersBiochemistryBiological MarkersBrainBrain InjuriesBrain PathologyBrain regionCell DeathCellsChronicChronic Brain DamageChronologyCitrullineCitrullinemiaClinicalClinical ResearchCognitiveComaDataDefectDevelopmentDietDiffusion Magnetic Resonance ImagingDiseaseDistalDoctor of PhilosophyEdemaEnsureExhibitsFemaleFunctional disorderGlutamineHyperammonemiaImpaired cognitionInjuryInositolLeadLesionLongitudinal StudiesMagnetic Resonance ImagingMeasuresMetabolicMethodologyMethodsMorbidity - disease rateNervous System TraumaNeurocognitiveNeurocognitive DeficitNeuropsychological TestsNitrogenOrnithineOrnithine carbamoyltransferase deficiencyOutcomePatientsPerformancePharmaceutical PreparationsPlasmaProcessRare DiseasesRecording of previous eventsResolutionSecondary toShort-Term MemoryStructural defectTest ResultTimeToxic effectadverse outcomecytotoxicexecutive functiongray mattermultidisciplinaryneurocognitive testneuroimagingneurological recoveryneuroprotectionneuropsychiatryneuropsychologicalneurotoxicnovelnovel strategiesspectroscopic imagingurea cyclewhite matter
中文摘要
在近端尿素循环障碍(UCD)中,特别是鸟氨酸转氨基甲酰基酶缺乏症(OTCD),高氨血症(HA)导致脑谷氨酰胺(Gin)增加,这被认为是神经损伤的核心。相反,在远端UCD中,如瓜氨酸血症(精氨酸琥珀酸合成酶缺乏症)和精氨酸琥珀酸尿症(精氨酸琥珀酸酶缺乏症);即使在没有急性HA的情况下,认知障碍和神经精神疾病也很常见。因此,瓜氨酸和精氨酸琥珀酸盐(ASA)或其代谢产物都被认为具有神经毒性。在这个项目中,我们将使用最先进的神经影像学和神经心理学方法来调查OTCD患者是否有慢性脑Gin升高和肌醇(ml)水平降低,这与区域脑结构异常和神经认知功能障碍有关。我们将进一步研究在HA急性发作期间,脑Gin升高和ml水平降低是否与细胞毒性水肿的程度相关,以及Gln/ml比值阈值是否可以确定细胞毒性水肿随后发生细胞损失。最后,我们将研究asd和/或ASLD的脑损伤区域是否与OTCD不同,并比较缺乏HA的asd和ASLD与OTCD的脑Gin水平。我们还将试图确定脑瓜氨酸和ASA是否可以在远端UCD患者的大脑中识别,以及它们是否与MRI和神经心理测试中看到的大脑异常相关。本项目将阐明急性高氨血症和慢性UCD的脑病理年表,以及近端和远端UCD在脑损伤的病理生理上是否不同。
英文摘要
In proximal urea cycle disorders (UCD), particularlyornithine transcarbamylase deficiency (OTCD), hyperammonemia (HA) causes increased brain glutamine (Gin) which perturbation is thoughtto be at the core of the neurological injury. In contrast, in distal UCD such as citrullinemia(argininosuccinatesynthetase deficiency; (ASSD) and argininosuccinicaciduria(argininosuccinatelyase deficiency); (ASLD) cognitive impairment and neuropsychiatric disease are common even in the absence of acute HA. As a consequence, both citrulline and argininosuccinate (ASA) or their metabolic products have been implicated as neurotoxic. In this project we will use state-of- the-art neuroimaging and neuropsychological methods to investigate whether patients with OTCD have chronically elevated brain Gin and reduced myo-inositol (ml) levels that correlate with regional brain structural abnormalities and neurocognitive dysfunction. We will further investigate whether during an acute episode of HA elevated brain Gin and decreased ml levels correlate with the magnitude of cytotoxic edema and whether a Gln/ml ratio threshold can be identified at which the cytotoxic edema is followed by cell loss. Finally, will investigate whether regions of brain damage in ASSD and/or ASLD are distinct from those in OTCD and compare brain Gin levels in ASSD and ASLD in the absence of HA to those in OTCD. We will also seek to determine if brain citrulline and ASA can be identified in the brains of patients with distal UCD and whether they correlate with brain abnormalities seen in MRI and neuropsychological testing. This project will elucidate the chronology of brain pathology both in acute hyperammonemia and chronic UCD and whether, proximal and distal UCD differ in their pathophysiology of brain damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Translation Core
-
批准号:10686082
-
项目类别:
-
资助金额:$14.89万
-
财政年份:2021
-
负责人:Andrea Lynne Gropman
-
依托单位:
Clinical Translation Core
-
批准号:10454192
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2021
-
负责人:Andrea Lynne Gropman
-
依托单位:
5th International Symposium on Urea Cycle Disorders
-
批准号:10318463
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2021
-
负责人:Andrea Lynne Gropman
-
依托单位:
Clinical Translation Core
-
批准号:10237681
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2021
-
负责人:Andrea Lynne Gropman
-
依托单位:
ASSESSING NEURAL MECHANISMS OF INJURY IN INBORN ERRORS OF UREA METABOLISM USING
-
批准号:7951976
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2009
-
负责人:Andrea Lynne Gropman
-
依托单位:
ASSESSING NEURAL MECHANISMS OF INJURY IN INBORN ERRORS OF UREA METABOLISM USI
-
批准号:7951991
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2009
-
负责人:Andrea Lynne Gropman
-
依托单位:
ASSESSING NEURAL MECHANISMS OF INJURY IN INBORN ERRORS OF UREA METABOLISM
-
批准号:7719061
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2008
-
负责人:Andrea Lynne Gropman
-
依托单位:
ASSESSING NEURAL MECHANISMS OF INJURY IN INBORN ERRORS OF METABOLISM
-
批准号:7719038
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2008
-
负责人:Andrea Lynne Gropman
-
依托单位:
Administrative Core
-
批准号:10670155
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Clinical-Res-Project2
-
批准号:10241409
-
项目类别:
-
资助金额:$15.49万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Administrative Core
-
批准号:10018946
-
项目类别:
-
资助金额:$51.93万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
-
批准号:10018931
-
项目类别:
-
资助金额:$162.72万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
-
批准号:9804379
-
项目类别:
-
资助金额:$188.76万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Clinical-Res-Project2
-
批准号:10670163
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Clinical-Res-Project2
-
批准号:10018950
-
项目类别:
-
资助金额:$15.64万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Administrative Core
-
批准号:10241407
-
项目类别:
-
资助金额:$50.31万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Rare Diseases Clinical Research Consortia (RDCRC) for the RDCR Network
-
批准号:9114135
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Administrative Core
-
批准号:10463795
-
项目类别:
-
资助金额:$46.97万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Clinical-Res-Project2
-
批准号:10463797
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
-
批准号:10463794
-
项目类别:
-
资助金额:$157.8万
-
财政年份:2003
-
负责人:Andrea Lynne Gropman
-
依托单位:
海外基金